Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02893579 · ClinicalTrials.gov registry record · NA
Stress Reduction Intervention for Women With Ischemic Heart Disease
A NA study, sponsored by NYU Langone Health.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT02893579 is a NA study that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 6 participants.
The verdict
NCT02893579, a NA study, was terminated before completion, sponsored by NYU Langone Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
This is a single center, randomized controlled trial which will include women with ischemic heart disease to receive either a self-directed stress reduction program delivered through a smart-phone application or activity tracking only for the first month ("early SR intervention" and "delayed SR intervention", respectively). Patients will be monitored for 1 month for application use and step counts via telephone or email interview and/or collection of screen-captured data. Baseline questionnaires will be repeated at the end of one month to assess for all primary and secondary measures, at which time the control group (activity tracking only) will be introduced to the intervention program. The early SR intervention group will not receive a new intervention but will be encouraged to continue using the app. Data will be collected for an additional 2 months with all participants in both groups. After the three-month study period, the study will close with the collection of final questionnaire data.
Interventions
- BEHAVIORAL Early SR intervention
- BEHAVIORAL Delayed SR intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2018-03-06 |
| Est. Completion | 2018-07-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02893579
The ClinicalTrials.gov registry entry for NCT02893579 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Early SR intervention is the first listed.
NCT02893579 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02893579 about?
NCT02893579 is a clinical study titled "Stress Reduction Intervention for Women With Ischemic Heart Disease". This is a single center, randomized controlled trial which will include women with ischemic heart disease to receive either a self-directed stress reduction program delivered through a smart-phone application or activity tracking only for the first month ("early SR intervention" and "delayed SR inte...
What is the current status of trial NCT02893579?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2018-03-06. Estimated completion is 2018-07-06.
What interventions are being tested in trial NCT02893579?
The interventions under investigation include: Early SR intervention (BEHAVIORAL), Delayed SR intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02893579?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.